The patient experienced severe back pain that he managed with steroids, leading to harmful side effects like weight gain and ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Nevro recently added a minimally invasive treatment option for patients in the U.S. suffering from chronic sacroiliac joint ( ...
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its third-quarter 2024 financial results, ...
The sacroiliac joint is a common source of chronic lower back pain and a novel RFA-based approach to sacroiliac joint denervation may provide intermediate-term pain relief and functional benefit ...
US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
Nevro recently added a minimally invasive treatment option for patients suffering from chronic sacroiliac joint ("SI joint") pain and now provides the most comprehensive portfolio of products in ...
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new data in the Journal of ...
We've joined forces with a panel of experts to bring you this ultimate guide to improving - or stopping - your back pain, based on the latest scientific research.